A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jonathan Drachman, MD
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
66 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Vincent'S Hospital - Sydney
Darlinghurst, New South Wales, Australia
- Gosford & Wyong Hospital
Gosford, New South Wales, Australia
- Royal North Shore Hospital
St Leonards, New South Wales, Australia
- the Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- St. Vincent'S Hospital, Melbourne
Fitzroy, Victoria, Australia
- Royal Perth Hospital
Perth, Western Australia, Australia
- Universite de Gent
Ghent, Belgium
- Az Sint-Augustinus
Wilrijk, Belgium
- Cliniques Universitaires Ucl de Mont-Goddine
Yvoir, Belgium
- Fakultni Nemocnice Hradec Kralove
Hradec Králové, Czechia
- Fakultni Nemocnice V Motole
Prague, Czechia
- Vseobecna Fakultni Nemocnice V Praze
Prague, Czechia
- Centre Hospitalier Andre Mignot
Le Chesnay, France
- Centre Leon Berard - Centre Regional de Lutte Contre Le Cancer Rhone-Alpes
Lyon, France
- Hopital Hotel Dieu
Nantes, France
- Groupe Hospitalier Necker - Enfants Malades
Paris, France
- Hopitaux Du Haut Leveque
Pessac, France
- Centre Hospitalier Lyon Sud
Pierre-Bénite, France
- Centre Henri Becquerel
Rouen, France
- Hematologie Chu Purpan
Toulouse, France
- Institut Gustave-Roussy
Villejuif, France
- Johannes-Gutenberg Universitat Mainz
Mainz, Germany
- Kh Maria Hilf-Franziskushaus
Mönchengladbach, Germany
- Universitatsklinikum Ulm
Ulm, Germany
- Debreceni Egyetem Orvos - Es Egeszsegtudomanyi Centrum
Debrecen, Hungary
- Petz Aladar Megyei Oktato Korhaz, Iind Department of Internal Medicine
Győr, Hungary
- Kaposi Mor Oktato Korhaz
Kaposvár, Hungary
- Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikat Kozpont
Szeged, Hungary
- Azienda Ospedaliera Universitaria Careggi
Florence, Italy
- Azienda Ospedaliera Universitaria San Martino
Genova, Italy
- Azienda Ospedaliera Universitaria Senese
Siena, Italy
- Szpital Akademii Medycznej W Gdansku
Gdansk, Poland
- Szpital Uniwersytecki W Krakowie
Krakow, Poland
- Wojewodzki Szpital Specjalistyczny Im. M. Kopernika W Lodzi
Lodz, Poland
- Centrum Onkologii Institut Im. Marii Sklodowskiej-Curie
Warsaw, Poland
- Instytut Hematologii I Transfuzjologii
Warsaw, Poland
- Samodzielny Publiczny Szpital Kliniczny Nr 1
Wroclaw, Poland
- H. Duran Y Reynals Institue Catala D'Oncologia
Barcelona, Spain
- Hospital Clinic I Provincial
Barcelona, Spain
- Hospital de la Santa Creu I Sant Paul
Barcelona, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2007
- Primary completion
- 31 Dec 2009
- Completion
- 31 May 2011
- Last update posted
- 25 Feb 2015
- Registered enrollment
- 151
- Registry id
- NCT00529503
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.